Ravi C Dara/LinkedIn
Oct 2, 2026, 12:50
Ravi C Dara: ADHAR 2026 – Red Cell Exchange in Sickle Cell Disease
Ravi C Dara, Consultant Physician Transfusion Medicine at Sheikh Shakhbout Medical City, shared a post on LinkedIn:
“Grateful for the opportunity to speak at ADHAR 2026 — the 3rd Abu Dhabi Haematology Annual Review — on ‘Red Cell Exchange in Sickle Cell Disease: The Case for Early, Optimised Therapy.’
It was a privilege to share our experience from the apheresis programme, and especially rewarding to see such active engagement from the audience — with several thoughtful questions following the talk.
Thank you Kourosh Lotfi, Kayane Mheidly, Aydah AlAwadhi for the invitation, and to everyone who attended and contributed to the discussion.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 13:50Louise Maes: CONVINCE Trial Imaging Studies Reveal New Insights Into Carotid Plaque and Vascular Risk
-
Nov 20, 2026, 13:50Lara Kurdi: A Presentation of Triple-Positive Antiphospholipid Syndrome
-
Nov 20, 2026, 13:46Rahul Bohra: Beyond Platelet Counts – The Lived Experience of ITP
-
Nov 20, 2026, 13:34Yohei Hisada: How Well Do Mouse Leukemia Models Reflect Human Disease?
-
Nov 20, 2026, 13:20Ilenia Calcaterra: The Inferior Thyroid Arteries as a Window Into Cardiovascular Risk
-
Nov 20, 2026, 13:03Does Being Fit Protect Against VTE? – RPTH Journal
-
Nov 20, 2026, 12:29Thirunavukkarasu Angappan: Antithrombin in ECMO – Two Datasets, Two Opposite Answers
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance
-
Nov 20, 2026, 11:33Tyler McConville: Why Hemostatic Function Matters More Than Cell Counts in Trauma and Transfusion